| Title： | Expert Consensus on Diagnosis and Treatment of Invasive Mold infection in Patients with Chronic Pulmonary Obstruction |
| Edition： | Original |
| Classification： | Experts consensus |
| Field： | Comprehensive guideline |
| Countries and regions： | China |
| Guidelines users： | Guide using department: Respiratory Department, Infection Department, Critical Illness Department, Internal Medicine Department, Surgery Department, Emergency Department, Inflammation and Immunization Department, etc. |
| Evidence classification method： | GRADE |
| Development unit： | Chinese Medical Association Respiratory Association Infection Group、Chinese Medical Association Respiratory Branch Chronic Obstructive Pulmonary Group |
| Registration time: | 2022-10-23 |
| Registration number： | PREPARE-2022CN670 |
| Purpose of the guideline: | Chronic obstructive pulmonary disease (COPD) patients, bronchiectasis, severe influenza, asthma and other diseases with pulmonary fungal infection constitute a serious clinical problem. The total number of patients with COPD in China is about 100 million. To further strengthen the clinical understanding, diagnosis and treatment of COPD patients with invasive fungal infection of the lung, and enhance the awareness of hospitals at all levels of high-risk patients with COPD patients with invasive fungal infection of the lung in the early stage, and to standardize the early diagnostic ability through imaging, microbiology and other means, Chinese Medical Association Respiratory Association Infection Group and Chinese Medical Association Respiratory Branch Chronic Obstructive Pulmonary Group jointly led Expert Consensus on Diagnosis and Treatment of Invasive Mold infecion in Patients with Chronic Pulmonary Obstruction. |
Latest registration
